Impaired Innate Immune Function Associated with Fecal Supernatant from Crohn's Disease Patients: Insights into Potential Pathogenic Role of the Microbiome
暂无分享,去创建一个
J. Korzenik | C. Clish | D. Nguyen | Stephen Cox | V. Yajnik | Parool Meelu | Garrett C. Zella | R. Marin
[1] Se Jin Song,et al. The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.
[2] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[3] M. Lukáš,et al. Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers , 2011, Inflammatory bowel diseases.
[4] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.
[5] N. Pace,et al. Disease phenotype and genotype are associated with shifts in intestinal‐associated microbiota in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.
[6] Francis K C Hui,et al. The arcsine is asinine: the analysis of proportions in ecology. , 2011, Ecology.
[7] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[8] Tariq Ahmad,et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.
[9] W. Strober. Gut microbes : friends or fiends ? , 2010 .
[10] S. Mazmanian,et al. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.
[11] S. Carr,et al. Metabolic Signatures of Exercise in Human Plasma , 2010, Science Translational Medicine.
[12] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[13] B. Nordestgaard,et al. Penetrance of NOD2/CARD15 genetic variants in the general population , 2010, Canadian Medical Association Journal.
[14] F. Avci,et al. How bacterial carbohydrates influence the adaptive immune system. , 2010, Annual review of immunology.
[15] R. Xavier,et al. Crohn's disease‐associated adherent‐invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly , 2010, Cellular microbiology.
[16] A. Sivignon,et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM , 2009, The Journal of experimental medicine.
[17] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[18] J. Jansson,et al. Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.
[19] M. Surette,et al. Effects of mesalamine (5‐aminosalicylic acid) on bacterial gene expression , 2009, Inflammatory bowel diseases.
[20] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[21] Judy H. Cho,et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.
[22] S. Mazmanian,et al. A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.
[23] Mario Vaneechoutte,et al. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora , 2008, Inflammatory bowel diseases.
[24] R. Knight,et al. The Human Microbiome Project , 2007, Nature.
[25] R. Xavier,et al. Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.
[26] I. Wilson,et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.
[27] P. Legendre,et al. vegan : Community Ecology Package. R package version 1.8-5 , 2007 .
[28] P. Rutgeerts,et al. Increased permeability of macroscopically normal small bowel in Crohn's disease , 1994, Digestive Diseases and Sciences.
[29] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[30] D. Podolsky,et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.
[31] J. Korzenik,et al. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. , 2000, Digestive diseases and sciences.
[32] K. H. Peterson,et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? , 1999, Gastroenterology.
[33] N. Barnich,et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.
[34] E. Lindberg,et al. Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. , 1995, Scandinavian journal of gastroenterology.
[35] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[36] L. Shapira,et al. Neutrophil Defects as Risk Factors for Periodontal Diseases. , 1994, Journal of periodontology.
[37] J. Paul Robinson,et al. Chapter 25 Functional Measurements Using HL-60 Cells , 1994 .
[38] J. Paul Robinson,et al. Functional measurements using HL-60 cells. , 1994, Methods in cell biology.
[39] T. J. Hurst,et al. Inhibition of polymorphonuclear leucocyte phagocytosis by Porphyromonas gingivalis culture products in patients with adult periodontitis. , 1993, Archives of oral biology.
[40] J T Boyle,et al. Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.
[41] J. Williams,et al. Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils. , 1989, Gut.
[42] G. Seymour,et al. Modulation of human neutrophil adherence by periodontopathic bacteria: reversal by specific monoclonal antibodies. , 1989, International archives of allergy and applied immunology.
[43] H. Ohta,et al. Leukotoxic Activity in Actinobacillus (Haemophilus) actinomycetemcomitans Isolated from Periodontal Disease Patients , 1987, Microbiology and immunology.
[44] R. Sjödahl,et al. Postprandial serum bile acids in resected and non-resected patients with Crohn's disease. , 1982, Scandinavian journal of gastroenterology.